New insights on diabetes mellitus and obesity in Africa-Part 2: Prevention, screening and economic burden

Heart

Volumn 99, Issue 15, 2013, Pages 1072-1077

  Kengne, Andre Pascal ^a,b,c   Sobngwi, Eugene ^d,e   Echouffo Tcheugui, Justin Basile ^f   Mbanya, Jean Claude ^d,g  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f EMORY UNIVERSITY   (United States)

^g UNIVERSITY OF TECHNOLOGY   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C;

AFRICA; ARTICLE; AWARENESS; COMORBIDITY; DIABETES CONTROL; DIABETES MELLITUS; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST;

METABOLIC MEDICINE;

ADULT; AFRICA; COMORBIDITY; COST OF ILLNESS; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PREVENTIVE HEALTH SERVICES; RISK FACTORS;

EID: 84880204758     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-303773     Document Type: Article

References (31)

1. International Diabetes Federation. In: Unwin N, Whiting D, Guariguata L, Ghyoot G, Gan D, eds. Updated Diabetes Atlas 2011. 5th ed. Brussels, 2011.
2. Kengne AP, Echouffo-Tcheugui J, Sobgnwi E, et al. New insights on diabetes mellitus and obesity in Africa-Part 1: prevalence, pathogenesis and comorbidities. Heart 2013;99:979-83.
3. Rawal LB, Tapp RJ, Williams ED, et al. Prevention of type 2 diabetes and its complications in developing countries: a review. Int J Behav Med 2012;19(2):121-33.
4. Colagiuri R, Girgis S, Gomez M, et al. National Evidence based guideline for the primary prevention of type 2 diabetes. In: NHMRC and diabetes Australia, eds. Canberra, 2009. Available at http://www.nhmrc.gov.au/-files-nhmrc/ publications/ attachments/di20.pdf (accessed 15 Mar 2013).
5. Echouffo-Tcheugui JB, Ali MK, Griffin SJ, et al. Screening for type 2 diabetes and dysglycemia. Epidemiol Rev 2011;33:63-87.
6. World Health Organisation. Noncommunicable diseases country profiles 2011. Geneva: WHO, 2011.
7. Sobngwi E, Ndour-Mbaye M, Boateng KA, et al. Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: the Diabcare Africa study. Diabetes Res Clin Pract 2012;95:30-6.
8. Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr 2010;2:1.
9. Youssef AA, El Mahalli AA, Akl OA, et al. Quality of diabetes care in primary care setting in egypt: an example of health sector reform in developing countries. J Egypt Public Health Assoc 2006;81:301-20.
10. Fatouh NF, Nour El-Din MM. Quality of diabetes care in family health facilities in one health district in alexandria. J Egypt Public Health Assoc 2009;84:457-78.
11. Chinenye S, Uloko AE, Ogbera AO, et al. Profile of Nigerians with diabetes mellitus - diabcare Nigeria study group (2008): results of a multicenter study. Indian J Endocrinol Metab 2012;16:558-64.
12. Sobgnwi E, Balde N. Translating evidence into practice: improving access to HbA1c in sub-Saharan Africa. Diabetes Voice 2011;56:37-9.
13. Gudina EK, Amade ST, Tesfamichael FA, et al. Assessment of quality of care given to diabetic patients at Jimma University Specialized Hospital diabetes follow-up clinic, Jimma, Ethiopia. BMC Endocr Disord 2011;11:19.
14. Kengne AP, Njamnshi AK, Mbanya JC. Cardiovascular risk reduction in diabetes in sub-Saharan-Africa: what should the Priorities be in the absence of global risk evaluation tools? Clin Med Cardiol 2008;2:25-31.
15. Echouffo-Tcheugui JB, Dagogo-Jack S. Preventing diabetes mellitus in developing countries. Nat Rev Endocrinol 2012;8:692.
16. Echouffo-Tcheugui JB, Mayige M, Ogbera AO, et al. Screening for hyperglycemia in the developing world: rationale, challenges and opportunities. Diabetes Res Clin Pract 2012;98:199-208.
17. Glumer C, Vistisen D, Borch-Johnsen K, et al. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care 2006;29:410-14. (Pubitemid 44106527)
18. Vistisen D, Lee CM, Colagiuri S, et al. A globally applicable screening model for detecting individuals with undiagnosed diabetes. Diabetes Res Clin Pract 2012;95:432-8.
19. Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012;380:1741-8.
20. Kirigia JM, Sambo HB, Sambo LG, et al. Economic burden of diabetes mellitus in the WHO African region. BMC Int Health Hum Rights 2009;9:6.
21. Elrayah-Eliadarous H, Yassin K, Eltom M, et al. Direct costs for care and glycaemic control in patients with type 2 diabetes in Sudan. Exp Clin Endocrinol Diabetes 2010;118:220-5.
22. Cavanagh P, Attinger C, Abbas Z, et al. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev 2012;28(Suppl 1):107-11.
23. Ortegon M, Lim S, Chisholm D, et al. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ 2012;344:e607.
24. Dzudie A, Choukem SP, Adam AK, et al. Prevalence and determinants of electrocardiographic abnormalities in sub-Saharan African individuals with type 2 diabetes. Cardiovasc J Afr 2012;23:533-7.
25. Ondoua JM, Kengne AP, Dehayem MY, et al. Cardiovascular preventative therapies and outcomes of care among urban sub-Saharan Africans with type 2 diabetes: a cross-sectional study in Cameroon. J Clin Outcomes Manage 2012;19:446-52.
26. Kengne AP, Limen SN, Sobngwi E, et al. Metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-Saharan Africans. Diabetol Metab Syndr 2012;4:22.
27. Elhwuegi A, Darez A, Langa A, et al. Cross-sectional pilot study about the health status of diabetic patients in city of Misurata, Libya. Afr Health Sci 2012;12:81-6.
28. Ogbera AO, Azenabor AO. Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetol Metab Syndr 2010;2:24.
29. Okafor CI, Ofoegbu EN. Control to goal of cardiometabolic risk factors among Nigerians living with type 2 diabetes mellitus. Niger J Clin Pract 2012;15:15-18.
30. Isezuo SA, Ezunu E. Demographic and clinical correlates of metabolic syndrome in Native African type-2 diabetic patients. J Natl Med Assoc 2005;97:557-63. (Pubitemid 40463586)
31. Alebiosu CO, Odusan BO. Metabolic syndrome in subjects with type-2 diabetes mellitus. J Natl Med Assoc 2004;96:817-21. (Pubitemid 38745790)